Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elizabeth Gerstner
National Cancer Institute (NCI)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- Adult Brain Tumor Consortium
Baltimore, Maryland, United States
- Johns Hopkins University/sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Charlestown, Massachusetts, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2010
- Primary completion
- 31 May 2012
- Completion
- 28 Feb 2014
- Last update posted
- 15 Apr 2015
- Registered enrollment
- 47
- Registry id
- NCT00979862
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.